Genetic evidence that intratumoral T-cell proliferation and activation are associated with recurrence and survival in patients with resected colorectal liver metastases Journal Article


Authors: Maker, A. V.; Ito, H.; Mo, Q.; Weisenberg, E.; Qin, L. X.; Turcotte, S.; Maithel, S.; Shia, J.; Blumgart, L.; Fong, Y.; Jarnagin, W. R.; De Matteo, R. P.; D'Angelica, M. I.
Article Title: Genetic evidence that intratumoral T-cell proliferation and activation are associated with recurrence and survival in patients with resected colorectal liver metastases
Abstract: Though immune responses correlate with prognosis in primary colorectal cancer, the role of tumor immunity in metastatic disease is less clear. We hypothesized that patient survival and tumor recurrence correlate with transcriptional evidence of lymphocyte proliferation/activation in resected colorectal cancer liver metastases (CRLM). Microarray gene analysis was performed on liver tumor specimens from 96 patients who underwent resection for CRLM. A Cox proportional hazards model identified genes associated with overall survival (OS) and recurrence-free survival (RFS). Conventional gene ontology (GO) enrichment analysis ranked biologically relevant processes. Survival probabilities of prioritized processes were assessed. Protein expression was validated with immunohistochemistry in an independent set of patients. GO analysis identified and ranked unique biologic processes that correlated with survival. Genes that specifically functioned in the biologic process of "T-cell proliferation" were significant predictors of OS (P = 0.01), and both "T-cell proliferation" and "activation" were highly associated with RFS (P < 0.01). Analysis of genes in these GO categories identified increased TNFSF14/LIGHT expression to be most associated with improved OS and RFS (P < 0.0006). Immunohistochemistry of an independent validation set of CRLM confirmed that both increased tumorinfiltrating lymphocytes (TIL) and higher LIGHT expression on TILs were associated with improved OS and RFS. Differential expression of genes involved in T-cell proliferation/activation was associated with survival outcomes in a large number of surgical patients who underwent resection of CRLM. These biologic functions determined by GO analysis of the tumor microenvironment have identified specific immune-related genes that may be involved in an antitumor immune response. © 2015 American Association for Cancer Research.
Journal Title: Cancer Immunology Research
Volume: 3
Issue: 4
ISSN: 2326-6066
Publisher: American Association for Cancer Research  
Date Published: 2015-04-01
Start Page: 380
End Page: 388
Language: English
DOI: 10.1158/2326-6066.cir-14-0212
PROVIDER: scopus
PMCID: PMC4390462
PUBMED: 25600439
DOI/URL:
Notes: Article -- Export Date: 2 May 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Qianxing Mo
    37 Mo
  2. Leslie H Blumgart
    352 Blumgart
  3. Ronald P DeMatteo
    637 DeMatteo
  4. Ajay V Maker
    10 Maker
  5. Shishir Kumar Maithel
    11 Maithel
  6. Hiromichi Ito
    15 Ito
  7. Li-Xuan Qin
    190 Qin
  8. Jinru Shia
    714 Shia
  9. William R Jarnagin
    903 Jarnagin
  10. Yuman Fong
    775 Fong